Skip to Main Content

For the second time in the past few months, a Democratic lawmaker is after Pfizer (PFE) to explain its pricing decisions, especially now that the drug maker is lifting a brief, self-imposed ban on price hikes with plans to boost the cost of more than 40 medicines next month.

In a letter to Pfizer chief executive Ian Read, Sen. Tammy Baldwin (D-Wis.) chastised him for “playing political games” by proceeding with the price hikes and for failing to answers questions that she posed last July, when Read tried to appease President Trump by rolling back a slew of increases.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!